3005

COM:JAFRON

健帆生物科技集团股份有限公司

  • Stock

Last Close

29.87

25/11 07:04

Market Cap

22.44B

Beta: -

Volume Today

5.29M

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '13
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
net income
126.78M
-
160.05M
26.24%
200.44M
25.24%
202.12M
0.84%
284.45M
40.74%
400.95M
40.95%
568.69M
41.84%
873.00M
53.51%
1.20B
36.98%
880.92M
26.33%
425.72M
51.67%
depreciation and amortization
2.46M
-
3.59M
46.00%
9.26M
157.94%
14.62M
57.78%
16.20M
10.81%
21.79M
34.54%
29.79M
36.69%
36.73M
23.29%
54.06M
47.19%
73.99M
36.88%
94.79M
28.11%
deferred income tax
-2.93M
-
-2.90M
0.95%
-17.23M
493.34%
-2.00M
88.39%
stock based compensation
17.13M
-
22.35M
30.50%
7.52M
66.37%
-8.73M
216.19%
change in working capital
2.94M
-
-28.79M
1,079.56%
-5.97M
79.27%
-40.79M
583.43%
28.38M
169.57%
-13.52M
147.64%
-1.75M
87.04%
36.00M
2,155.17%
-302.31K
100.84%
-101.99M
33,636.41%
291.05M
385.38%
accounts receivables
-34.23M
-
-83.41M
143.69%
-110.41M
32.38%
-7.90M
92.84%
inventory
-186.28K
-
-8.31M
4,360.95%
-4.73M
43.09%
-10.92M
130.94%
4.38M
140.13%
-15.87M
462.09%
-31.20M
96.62%
-28.29M
9.34%
-75.93M
168.42%
-152.74M
101.16%
-37.30M
75.58%
accounts payables
66.61M
-
150.60M
126.08%
203.27M
34.98%
60.66M
70.16%
other working capital
3.13M
-
-20.48M
755.27%
-1.24M
93.95%
-29.87M
2,309.48%
23.99M
180.33%
2.35M
90.20%
-2.93M
224.69%
-2.90M
0.95%
-17.23M
493.34%
-2.00M
88.39%
other non cash items
1.14M
-
2.50M
119.08%
1.44M
42.41%
2.69M
86.72%
-24.93M
1,026.48%
-25.14M
0.84%
-27.43M
9.11%
-7.68M
72.00%
9.52M
224.01%
41.61M
336.86%
72.52M
74.30%
net cash provided by operating activities
133.33M
-
137.35M
3.02%
205.18M
49.38%
178.64M
12.94%
304.10M
70.23%
384.08M
26.30%
583.50M
51.92%
957.49M
64.10%
1.25B
30.49%
883.80M
29.26%
916.74M
3.73%
investments in property plant and equipment
-63.14M
-
-64.29M
1.82%
-61.40M
4.49%
-28.66M
53.33%
-177.73M
520.24%
-173.53M
2.36%
-220.67M
27.17%
-357.11M
61.83%
-537.41M
50.49%
-475.89M
11.45%
-247.25M
48.04%
acquisitions net
-1.67M
-
-897.07K
46.40%
-500K
44.26%
28.83M
5,866.19%
-12.10M
141.97%
-28.88M
138.65%
-6.28M
78.27%
357.93M
5,802.40%
987.30K
99.72%
6.91M
599.46%
purchases of investments
-300M
-
-2.29B
663.33%
-3.62B
57.91%
-2.84B
21.39%
-1.31B
53.92%
-4.55B
247.60%
-2.05B
54.98%
-15M
99.27%
sales maturities of investments
202.04M
-
2.42B
1,098.00%
3.56B
47.23%
2.87B
19.39%
1.33B
53.87%
4.42B
233.51%
2.21B
49.92%
other investing activites
3.83M
-
63.93K
98.33%
1.42K
97.77%
-28.66M
2,014,074.89%
70.35K
100.25%
380.51
99.46%
18.80K
4,840.74%
-357.11M
1,899,643.18%
0.70
100.00%
-184.02K
26,289,243.54%
net cash used for investing activites
-60.99M
-
-65.12M
6.78%
-61.90M
4.95%
-126.44M
104.26%
-59.33M
53.07%
-254.93M
329.64%
-197.12M
22.67%
-341.11M
73.04%
-670.22M
96.48%
-305.90M
54.36%
-249.65M
18.39%
debt repayment
-998.30M
-
-296.32M
70.32%
-418.42M
41.21%
common stock issued
-498.17M
-
-291.12M
41.56%
common stock repurchased
-5.34M
-
-8.29M
55.13%
-500.13M
5,935.60%
-5.19M
98.96%
dividends paid
-37.50M
-
-87.75M
134%
-88.80M
1.20%
-83.32M
-
-146.16M
75.41%
-251.01M
71.74%
-377.81M
50.52%
-531.02M
40.55%
-729.42M
37.36%
-561.79M
22.98%
other financing activites
420.56M
-
139.63M
66.80%
31.65M
77.34%
60.91M
92.47%
73.07M
19.96%
2.69B
3,585.34%
956.12M
64.49%
-308.55M
132.27%
net cash used provided by financing activities
-37.50M
-
-87.75M
134%
-88.80M
1.20%
420.56M
573.61%
56.31M
86.61%
-114.51M
303.34%
-195.44M
70.68%
-313.03M
60.16%
165.18M
152.77%
-365.93M
321.54%
-451.91M
23.50%
effect of forex changes on cash
-30.15
-
0.03
100.10%
0.50
1,566.67%
0.55
10.00%
192.58
34,914.55%
4.16K
2,058.13%
-540.93
113.02%
-35.50K
6,463.14%
-4.81
99.99%
-36.40K
756,607.69%
11.39K
131.30%
net change in cash
34.84M
-
-15.52M
144.55%
54.48M
451.04%
472.76M
767.81%
301.07M
36.32%
14.64M
95.14%
190.93M
1,203.83%
303.32M
58.87%
744.37M
145.41%
211.93M
71.53%
215.19M
1.54%
cash at beginning of period
213.53M
-
248.37M
16.31%
232.85M
6.25%
287.33M
23.40%
760.08M
164.54%
1.06B
39.61%
1.08B
1.38%
1.27B
17.75%
1.57B
23.95%
2.31B
47.41%
2.53B
9.16%
cash at end of period
248.37M
-
232.85M
6.25%
287.33M
23.40%
760.08M
164.54%
1.06B
39.61%
1.08B
1.38%
1.27B
17.75%
1.57B
23.95%
2.31B
47.41%
2.53B
9.16%
2.74B
8.52%
operating cash flow
133.33M
-
137.35M
3.02%
205.18M
49.38%
178.64M
12.94%
304.10M
70.23%
384.08M
26.30%
583.50M
51.92%
957.49M
64.10%
1.25B
30.49%
883.80M
29.26%
916.74M
3.73%
capital expenditure
-63.14M
-
-64.29M
1.82%
-61.40M
4.49%
-28.66M
53.33%
-177.73M
520.24%
-173.53M
2.36%
-220.67M
27.17%
-357.11M
61.83%
-537.41M
50.49%
-475.89M
11.45%
-247.25M
48.04%
free cash flow
70.18M
-
73.06M
4.11%
143.78M
96.78%
149.98M
4.32%
126.37M
15.74%
210.55M
66.62%
362.82M
72.32%
600.37M
65.47%
712.00M
18.59%
407.91M
42.71%
669.49M
64.13%

All numbers in (except ratios and percentages)